These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Non-parallelism in the one-stage coagulation factor assay is a phenomenon of lupus anticoagulants and not of individual factor inhibitors. Ruinemans-Koerts J; Peterse-Stienissen I; Verbruggen B Thromb Haemost; 2010 Nov; 104(5):1080-2. PubMed ID: 20806127 [No Abstract] [Full Text] [Related]
67. Post partum renal failure in systemic lupus erythematosus associated with circulating lupus anticoagulant and anticardiolipin antibody. Kincaid-Smith P Clin Nephrol; 1991 Jul; 36(1):52. PubMed ID: 1909612 [No Abstract] [Full Text] [Related]
69. Circulating lupus anticoagulant in a surgical temporomandibular joint patient. Report of a case. Carlson ER; Catone GA Oral Surg Oral Med Oral Pathol; 1988 Apr; 65(4):404-5. PubMed ID: 3129685 [TBL] [Abstract][Full Text] [Related]
70. Antinuclear antibody-negative systemic lupus erythematosus (SLE) and severe renal involvement: close correlation between disease activity and appearance of circulating anticoagulant. Raz E; Michaeli J; Rosenmann E; Rubinow A; Popovtzer MM Isr J Med Sci; 1988 Feb; 24(2):105-8. PubMed ID: 3128493 [TBL] [Abstract][Full Text] [Related]
71. Acquired coagulation inhibitor-associated bleeding disorders: an update. Franchini M; Veneri D Hematology; 2005 Dec; 10(6):443-9. PubMed ID: 16321808 [TBL] [Abstract][Full Text] [Related]
72. [A case of systemic lupus erythematosus associated with acquired von Willebrand's syndrome and circulating anticoagulant]. Maeda T; Ando T; Nakamura Y; Ishida H; Kikuchi K; Iimura O; Shikano Y Nihon Naika Gakkai Zasshi; 1984 May; 73(5):680-5. PubMed ID: 6436413 [No Abstract] [Full Text] [Related]
73. Decreased fibrinolytic capacity and increased von Willebrand factor levels as indicators of endothelial cell dysfunction in patients with lupus anticoagulant. Nilsson TK; Löfvenberg E Clin Rheumatol; 1989 Mar; 8(1):58-63. PubMed ID: 2501064 [TBL] [Abstract][Full Text] [Related]
75. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Lechner K; Pabinger-Fasching I Haemostasis; 1985; 15(4):254-62. PubMed ID: 3930350 [TBL] [Abstract][Full Text] [Related]
76. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease. Mannucci PM; Mari D Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422 [No Abstract] [Full Text] [Related]
77. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage. O'Connor CR Semin Arthritis Rheum; 2015 Jun; 44(6):695-709. PubMed ID: 25595725 [TBL] [Abstract][Full Text] [Related]
78. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus]. Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004 [No Abstract] [Full Text] [Related]
79. [Circulating anticoagulants in systemic lupus. Apropos of 60 patients. Multicenter study conducted by the research department of the SNFMI]. Le Thi Huong Du; Guillevin L; Arlet Suau E; Bercoff E; Pasquali JL; Beylot J; Kaloustian E; Garabedian C; Agius D; Beaugrand M Ann Med Interne (Paris); 1987; 138(4):246-50. PubMed ID: 3115165 [No Abstract] [Full Text] [Related]
80. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Hughes GR Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1088-9. PubMed ID: 6414579 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]